Instrument Inactif

Communiqués Precision Therapeutics Inc Nasdaq

Actions

US74033P1003

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors	12/06	AQ
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)	11/06	AQ
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery	04/06	AQ
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be presented at the 2024 American Society of Clinical Oncology Annual Meeting	29/05	AQ
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024	29/05	AQ
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	28/05	AQ
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update	15/05	AQ
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	13/05	AQ
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	10/05	AQ
Predictive Oncology : Material Agreement - Form 8-K	06/05	PU
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine	30/04	AQ
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	25/04	AQ
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04	AQ
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update	28/03	AQ
Predictive Oncology to Participate in Upcoming Investor Conferences	21/02	AQ
Predictive Oncology to Participate in Upcoming San Francisco Conferences	02/01	AQ
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update	14/11	AQ
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital	09/11	AQ
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital	08/11	AQ
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023	07/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Precision Therapeutics Inc Nasdaq

Actions

US74033P1003

Communiqués

Filtres